• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

背景体素信号抑制的扩散加权全身成像在检测生殖细胞癌转移灶中的应用。

The utility of diffusion-weighted whole-body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma.

作者信息

Yoshitomi Kasumi Kaneko, Numao Noboru, Umino Yosuke, Fujiwara Motohiro, Fujiwara Ryo, Oguchi Tomohiko, Komai Yoshinobu, Yuasa Takeshi, Yamamoto Shinya, Yonese Junji

机构信息

Department of Urology Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan.

Department of Urology Showa General Hospital Tokyo Japan.

出版信息

IJU Case Rep. 2021 Jun 16;4(5):285-288. doi: 10.1002/iju5.12327. eCollection 2021 Sep.

DOI:10.1002/iju5.12327
PMID:34497984
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8413202/
Abstract

INTRODUCTION

Although the utility of diffusion-weighted whole-body imaging with background body signal suppression for assessing lymph node involvement or distant metastasis is renowned in many cancers, only few studies have revealed its utility for germ cell carcinoma. Some metastatic lesions of germ cell carcinomas are difficult to detect by conventional imaging.

CASE PRESENTATION

We report a case of a 70-year-old man with relapsed retroperitoneal germ cell tumor. Although his human chorionic gonadotropin levels increased, conventional imaging analysis showed no evidence of recurrence. Diffusion-weighted whole-body imaging with background body signal suppression was performed to search the metastatic lesion and detected metastatic sacral lesions. The patient responded well to local radiotherapy added to the steroid pulse and salvage chemotherapy and achieved long-term recurrence-free survival.

CONCLUSION

Diffusion-weighted whole-body imaging with background body signal suppression has the potential to detect metastatic lesions not usually detected by conventional imaging methods.

摘要

引言

尽管背景体部信号抑制的扩散加权全身成像在评估许多癌症的淋巴结受累或远处转移方面的效用广为人知,但仅有少数研究揭示了其在生殖细胞癌中的效用。生殖细胞癌的一些转移病灶难以通过传统成像检测到。

病例报告

我们报告一例70岁复发性腹膜后生殖细胞肿瘤男性患者。尽管其血清人绒毛膜促性腺激素水平升高,但传统成像分析未显示复发迹象。进行背景体部信号抑制的扩散加权全身成像以寻找转移病灶,并检测到骶骨转移病灶。该患者对加用类固醇脉冲和挽救性化疗的局部放疗反应良好,并实现了长期无复发生存。

结论

背景体部信号抑制的扩散加权全身成像有潜力检测出通常无法通过传统成像方法检测到的转移病灶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8413202/20d2356e9ed5/IJU5-4-285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8413202/22ffa1704768/IJU5-4-285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8413202/f7af0b526a45/IJU5-4-285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8413202/20d2356e9ed5/IJU5-4-285-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8413202/22ffa1704768/IJU5-4-285-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8413202/f7af0b526a45/IJU5-4-285-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bef/8413202/20d2356e9ed5/IJU5-4-285-g002.jpg

相似文献

1
The utility of diffusion-weighted whole-body imaging with background body signal suppression in detecting metastatic lesion of germ cell carcinoma.背景体素信号抑制的扩散加权全身成像在检测生殖细胞癌转移灶中的应用。
IJU Case Rep. 2021 Jun 16;4(5):285-288. doi: 10.1002/iju5.12327. eCollection 2021 Sep.
2
Two cases of oligometastatic castration-resistant prostate cancer detected by diffusion-weighted whole-body imaging with background body signal suppression.两例经背景体部信号抑制的扩散加权全身成像检测到的寡转移去势抵抗性前列腺癌病例。
IJU Case Rep. 2020 Feb 17;3(2):65-68. doi: 10.1002/iju5.12146. eCollection 2020 Mar.
3
Diffusion-weighted whole-body imaging with background suppression (DWIBS) is effective and economical for detection of metastasis or recurrence of lung cancer.弥散加权全身成像(DWIBS)联合背景抑制技术对肺癌转移或复发的检测具有有效性和经济性。
Thorac Cancer. 2021 Mar;12(5):676-684. doi: 10.1111/1759-7714.13820. Epub 2021 Jan 21.
4
Diagnostic performance of F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描(F-FDG PET/CT)及背景体部抑制全身扩散加权成像(DWIBS)在检测小儿神经母细胞瘤淋巴结及骨转移中的诊断效能
Ann Nucl Med. 2018 Jun;32(5):348-362. doi: 10.1007/s12149-018-1254-z. Epub 2018 Apr 17.
5
Whole-body MRI for metastatic cancer detection using T -weighted imaging with fat and fluid suppression.全身 MRI 采用 T1 加权成像结合脂肪和液体抑制技术检测转移性癌症。
Magn Reson Med. 2018 Oct;80(4):1402-1415. doi: 10.1002/mrm.27117. Epub 2018 Feb 14.
6
Stereotactic Body Radiotherapy for a Sacral Metastasis Clarified by Diffusion-Weighted Whole-Body Imaging With Background Body Signal Suppression in a Patient With Castration-Resistant Prostate Cancer.立体定向体部放射治疗用于去势抵抗性前列腺癌患者经背景体部信号抑制的扩散加权全身成像明确的骶骨转移瘤
Cureus. 2022 Mar 10;14(3):e23047. doi: 10.7759/cureus.23047. eCollection 2022 Mar.
7
Clinical value of whole-body magnetic resonance diffusion weighted imaging on detection of malignant metastases.全身磁共振扩散加权成像在检测恶性转移瘤中的临床价值
Chin Med Sci J. 2009 Jun;24(2):112-6. doi: 10.1016/s1001-9294(09)60072-9.
8
Retroperitoneal metastatic squamous cell carcinoma of the tonsil (with elevated beta human chorionic gonadotrophin): a misdiagnosis as extra-gonadal germ cell tumour.扁桃体腹膜后转移性鳞状细胞癌(伴β-人绒毛膜促性腺激素升高):误诊为性腺外生殖细胞肿瘤
J Laryngol Otol. 2006 Oct;120(10):885-7. doi: 10.1017/S0022215106001642. Epub 2006 May 23.
9
Carcinoma of unknown primary detected by whole-body diffusion-weighted imaging: A case report and review of the literature.通过全身弥散加权成像检测到的原发性不明癌:一例报告并文献复习
Radiol Case Rep. 2020 May 12;15(7):983-987. doi: 10.1016/j.radcr.2020.04.002. eCollection 2020 Jul.
10
Preliminary study of whole-body diffusion-weighted imaging in detecting pulmonary metastatic lesions from clear cell renal cell carcinoma: comparison with CT.全身扩散加权成像在检测透明细胞肾细胞癌肺转移瘤中的初步研究:与CT的比较
Acta Radiol. 2011 Nov 1;52(9):954-63. doi: 10.1258/ar.2011.110121. Epub 2011 Sep 8.

本文引用的文献

1
Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.非风险适应的 I 期睾丸癌监测:关键评价和总结。
Eur Urol. 2018 Jun;73(6):899-907. doi: 10.1016/j.eururo.2017.12.030. Epub 2018 Jan 12.
2
Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.与(18)F-FDG PET/CT相比,WB-MR/DWIBS在淋巴瘤治疗反应评估中的作用。
Radiol Med. 2016 Feb;121(2):132-43. doi: 10.1007/s11547-015-0581-6. Epub 2015 Sep 9.
3
Guidelines on Testicular Cancer: 2015 Update.睾丸癌诊疗指南:2015 年更新版
Eur Urol. 2015 Dec;68(6):1054-68. doi: 10.1016/j.eururo.2015.07.044. Epub 2015 Aug 18.
4
Whole body MRI, including diffusion-weighted imaging in follow-up of patients with testicular cancer.全身磁共振成像,包括在睾丸癌患者随访中的扩散加权成像。
Acta Oncol. 2015 Nov;54(10):1763-9. doi: 10.3109/0284186X.2015.1043027. Epub 2015 May 15.
5
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.临床Ⅰ期睾丸生殖细胞肿瘤主动监测患者复发模式。
J Clin Oncol. 2015 Jan 1;33(1):51-7. doi: 10.1200/JCO.2014.56.2116. Epub 2014 Aug 18.
6
Whole-body-MR-diffusion weighted imaging in oncology.肿瘤学中的全身磁共振扩散加权成像
Rofo. 2013 Sep;184(10):950-8. doi: 10.1055/s-0033-1335428. Epub 2013 Sep 2.
7
The clinical application of whole-body diffusion-weighted imaging in the early assessment of chemotherapeutic effects in lymphoma: the initial experience.全身扩散加权成像在淋巴瘤化疗疗效早期评估中的临床应用:初步经验。
Magn Reson Imaging. 2012 Feb;30(2):165-70. doi: 10.1016/j.mri.2011.09.019. Epub 2011 Nov 30.
8
Whole-body MR-DWIBS vs. [18F]-FDG-PET/CT in the study of malignant tumors: a retrospective study.全身磁共振弥散加权成像与 [18F]-FDG-PET/CT 对恶性肿瘤的研究:一项回顾性研究。
Radiol Med. 2012 Mar;117(2):293-311. doi: 10.1007/s11547-011-0708-3. Epub 2011 Jul 9.
9
Whole-body MRI for the staging and follow-up of patients with metastasis.全身MRI用于转移瘤患者的分期及随访。
Eur J Radiol. 2009 Jun;70(3):393-400. doi: 10.1016/j.ejrad.2009.03.045. Epub 2009 May 19.
10
[Occult lumbar vertebral body metastasis of non-seminomatous germ cell tumor eradicated by radiation and salvage surgery 9 years after initial onset].[非精原细胞瘤性生殖细胞肿瘤隐匿性腰椎椎体转移在初发9年后经放疗及挽救性手术根除]
Nihon Hinyokika Gakkai Zasshi. 2007 May;98(4):634-7. doi: 10.5980/jpnjurol1989.98.634.